Effects of glibornuride versus metformin on eye lenses and skin in experimental diabetes

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 7, 2006, Pages 541-546

  Yarat, Aysen ^a   Yanardaǧ, Refiye ^b   Tunali, Tugba ^a   Sacan, Ozlem ^b   Gursoy, Fusun ^a   Emekli, Nesrin ^a   Ustuner, Ali ^c   Ergenekon, Gönül ^d  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

Author keywords

Antidiabetic drugs; CAS 26944 48 9; CAS 657 24 9; Diabetes mellitus, eye lens, skin, tissue protection; Glibornuride; Metformin

Indexed keywords

DODECYL SULFATE SODIUM; GLIBORNURIDE; GLUCOSE; GLUTATHIONE; METFORMIN; ORAL ANTIDIABETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GEL ELECTROPHORESIS; GLUCOSE BLOOD LEVEL; GLYCATION; LENS; LIPID PEROXIDATION; NONHUMAN; RAT; SKIN; STREPTOZOCIN DIABETES;

EID: 33746893481     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296749     Document Type: Article

References (42)

1. Maritim, A. C., Sanders, R. A., Watkins, J. B., Diabetes, oxidative stress and antioxidants: a review. J. Biochem. Mol. Toxicol. 17, 24 (2003)
2. Ramachandran, B., Ravi, K., Narayanan, V. et al., Effect of macrocyclic binuclear oxovanadium complex on tissue defense system in streptozotocin-induced diabetic rats. Clin. Chim. Acta 345, 141 (2004)
3. Yarat, A., Tunali, T., Yanardag, R. et al., The effect of glurenorm (Gliquidone) on lenses and skin in experimental diabetes. Free Radic. Biol. Med. 31, 1038 (2001)
4. Logie, A. W., Stowers, J. W., Clinical trial of glibornuride in diabetes. Br. Med. J. 3, 514 (1975)
5. Seufert, J., Lubben, G., Dietrich, K. et al., A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus. Clin. Ther. 26, 805 (2004)
6. Lebovitz, H. E., Alpha-glucosidase inhibitors. Endocrinol. Metab. Clin. North. Am. 26, 539 (1997)
7. Bolkent, S., Yanardaǧ, R., Karabulut-Bulan, O. et al., The morphological and biochemical effects of glibornuride on rat liver in experimental diabetes. Hum. Exp. Toxicol. 23, 257 (2004)
8. Wingard, L. B., Brody, T. M., Larner, J. et al., Human Pharmacology, Molecular-to-clinical, p. 546. Mosby Year Book, St. Louis (1991)
9. Campell, I. W., Howlett, H. C. S., Worldwide experience of metformin as an effective glucose lowering agent. A meta-analysis. Diabetes Metab. Rev. 11, S57 (1995)
10. Hermann, L. S., Clinical Pharmacology of Biguanides. In: Born, G. V. R., Cuatrecasas, P., Ganten, D. et al. (eds.), Handbook of Experimental Pharmacology, vol. 119, pp. 373-407. Springer, Berlin (1996)
11. Hermann, L. S., Metformin: A review of its pharmacological properties and therapatic use. Diabetes Metab. 5, 233 (1979)
12. Baily, C. J., Metformin - an update. General Pharmacol. 24, 1299 (1993)
13. Dunn, C. J., Peters, D. H., Metformin, A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 49, 721 (1995)
14. Baily, C. J., Turner, R., Metformin. In: Drug Therapy, Alastair, J. J., Wood, M. D. (eds.). N. Engl. J. Med. 334, 574 (1996)
15. Relander, A., Raiha, C. E., Differences between the enzymatic and o-toluidine methods of blood glucose determination. Scand. J. Clin. Lab. Invest. 15, 221 (1963)
16. Lowry, O. H., Rosebrough, W. I., Farr, A. L. et al., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 (1951)
17. Parker, K. M., England, J. D., Da Costa, J. et al., Improved colorimetric assay for glycosylated hemoglobin. Clin. Chem. 27, 669 (1981)
18. Ledwozyw, A., Michalak, J., Stepien, A. et al., The relationship between plasma triglycerides, cholesterol, total lipids, and lipid peroxidation products during human atherosclerosis. Clin. Chim. Acta 155, 275 (1986)
19. Beutler, E., Glutathione in red blood cell metabolism: a manual of biochemical methods, 2nd ed., pp 112-114. Grune and Stratton, New York (1975)
20. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680 (1970)
21. Hintze, J. L., Number cruncher statistical system, Version 5.0. NCSS - Number Crunching Statistical System, Kaysville, Utah
22. Yarat, A., Özçelik, F., Yanardǎǧ, R. et al., The effect of chard (Beta vulgaris L. var cicla) on the protein and antioxidant system in the lenses of streptozotocin-induced diabetic rats. J. Pharm. Pharmacol. Comm. 4, 271 (1998)
23. Tunali, T., Yarat, A., Yanardaǧ, R. et al., The effect of chard (Beta vulgaris L. var cicla) on the skin of streptozotocin-induced diabetic rats. Pharmazie 53, 638 (1998)
24. Aiello, L. M., Cavallerano, J. D., Ocular complications of diabetes mellitus. In: Kahn, C. R., Weir, G. C. (eds.), Joslin's diabetes mellitus, pp. 771-793. Lea & Febiger, Baltimore (1994)
25. King, G. L., Branskota, N. K., Mechanism of diabetic microvascular complications. In: Kahn, C. R., Weir, G. C., (eds.). Joslin's diabetes mellitus, pp. 631-647. Lea & Febiger, Baltimore (1994)
26. Chait, A., Bierman, E. L., Pathogenesis of macrovascular disease in diabetes. In: Kahn, C. R., Weir, G. C. (eds.), Joslin's diabetes mellitus, pp. 648-664. Lea & Febiger, Baltimore (1994)
27. Cohen, A. M., Yanko, L., Rosenmann, E., Control of blood glucose levels and development of diabetic microangiopathy: effects of glibornuride. Isr. J. Med. Sci. 19, 311 (1983)
28. El Tahir, K. E., Ali, A. E., Abu Nasif, M. A. et al., The influence of oral hypoglycaemic sulfonylureas on prostacyclin release by the rat thoracic aorta. Arch. Int. Pharmacodyn. Ther. 283, 134 (1986)
29. Cakir, B., Ayvaz, G., Cakir, N. et al., Effect of glybornuride on plasma level of atrial natriuretic factor in patients with newly diagnosed NIDDM. Endocr. Regul. 32, 27 (1998)
30. Aviles-Santa, L., Sinding, J., Raskin, P., Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. Ann. Intern. Med. 131, 182 (1999)
31. Garber, A. J., Duncan, T. G., Goodman, A. M. et al., Efficacy of metformin in type II diabetes: results of a double-blind, placebo-cotrolled, dose-response trial. Am. J. Med. 102, 491 (1997)
32. Verma, S., McNell, J. H., Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts. Am. J. Physiol. 266, H714 (1994)
33. Mather, K. J., Verma, S., Anderson, T. J., Improved endothelial function with metformin in type 2 diabetes mellitus. J. Am. Coll. Cardiol. 17, 1344 (2001)
34. Lupi, R., Del Guerra, S., Tellini, C. et al., The biguanid compound metformin prevents desensitization of human pancreatic islets induced by high glucose. Eur. J. Pharmacol. 364, 205 (1999)
35. Jyothirmayi, G. N., Soni, B. J., Masurekar, M. et al., Effects of Metformin on collagen glycation and diastolic dysfunction in diabetic myocardium. J. Cardiovasc. Pharmacol. Ther. 3, 319 (1998)
36. Nagi, D. K., Yudkin, J. S., Effect of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activation inhibitors in NIDDM subjects. A study of two ethnic groups. Diabetes Care 16, 621 (1993)
37. Sener, G., Sacan, O., Yanardaǧ, R. et al., The effect of metformin and chard extract on aorta lipid peroxidation in experimental diabetes. First International Obesity Symposiun and 32nd National Diabetes Congress, 15-19 April 1996, Antalya-Belek (Turkey); 115 (1996)
38. Tessier, D., Maheux, P., Khalil, A. et al., Effects of Gliclazide versus metformin on clinical profile and lipid peroxidation markers in type 2 diabetes. Metabolism 48, 897 (1999)
39. Hamann, A., Benecke, H., Greten, H. et al., Metformin increases glucose transporter protein and gene expression in human fibroblasts. Biochem. Biophys. Res. Commun. 196, 82 (1993)
40. Wilcock, C., Bailey, C. J., Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica 24, 49 (1994)
41. Schafer, G., Biguanides: Molecular mode of action. In: Cudworth, A. G. (ed.), Metformin: Current Aspect and Future Developments (Proceeding of a Symposium held at the Lido de France, Jersey, 5/6 May 1979), Res. Clin. Forums 1, 122 (1979)
42. Beisswenger, P. J., Howel, S. K., Touchette, A. D. et al., Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 48, 98 (1999)